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Background: Adiponectin circulates in different multimer complexes comprised of low molecular weight trimeric
form (LMW), hexamer of middle molecular weight (MMW) and high molecular weight multimers (HMW). In
Japanese-Brazilians, a population with high prevalence of glucose metabolism disturbances, we examined the
associations of total adiponectin and its multimers with diabetes mellitus.
Methods: Two study groups were examined: 26 patients with diabetes mellitus (DM,14 women and 12 men, aged
55.3 ± 8.6 years) and 27 age-matched control subjects with normal glucose tolerance (NGT,12 women and 15 men,
aged 54.0 ± 9.2 years).
Results: We found no significant differences in total [NGT: 6.90 ug/ml (4.38-13.43); DM: 5.38 ug/ml (3.76-8.56), p = 0.35],
MMW [NGT:2.34 ug/ml (1.38-3.25); DM: 1.80 ug/ml (1.18-2.84), p = 0.48] or LMW adiponectin [NGT: 2.07 ug/ml (1.45-3.48),
DM: 2.93 ug/ml (1.78-3.99), p = 0.32] between groups. In contrast, HMW adiponectin levels were significantly lower in
patients with DM [TGN: 2.39 ug/ml (1.20-4.75); DM: 1.04 ug/ml (0.42-1.60), p = 0.001]. A logistic regression analysis was
done to identify independent associations with diabetes mellitus. The results showed that HOMA-IR and HMW
adiponectin in women were independently associated with diabetes mellitus.
Conclusion: The current investigation demonstrates that in Japanese-Brazilians HMW adiponectin is selectively reduced
in individuals with type 2 diabetes, while no differences were found in MMW and LMW adiponectin isoforms.
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Adiponectin, a peptide hormone predominantly expressed
and secreted by adipocytes, has been recognized as an im-
portant regulator of insulin sensitivity [1-3]. It is present in
the circulation of healthy individuals at high concentration,
account for approximately 0.01% of total plasma protein.
Hypoadiponectinemia is seen in states of insulin resistance
such as type 2 diabetes, obesity and metabolic syndrome
[4-6]. Adiponectin circulates in different multimer com-
plexes comprised of low molecular weight trimeric form
(LMW), hexamer of middle molecular weight (MMW) and
high molecular weight multimers (HMW) [7]. Possibly
these complexes have different functions and there are evi-
dences indicating that HMW adiponectin might be the
most active metabolically form. Indeed, previous studies* Correspondence: rmoises@unifesp.br
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reproduction in any medium, provided the orshowed that HMW adiponectin or the ratio HMW to total
adiponectin correlates better with measures of insulin
sensitivity [8,9] or glucose tolerance [10]. However, other
studies failed to demonstrate the superiority of HMW
adiponectin over total adiponectin in assessing insulin
sensitivity. For example, in a Mexican population total
adiponectin, HMW adiponectin and the ratio HMW/total
adiponectin had similar utility for the identification of in-
sulin resistance and metabolic disturbances [11]. Similarly,
in a longitudinal study with Japanese-Americans lower
both total and HMW adiponectin were independent risk
factors for the development of metabolic syndrome [12].
Japanese-Brazilian is a population with high prevalence
of glucose metabolism disturbances, being the preva-
lence of diabetes one of the highest worldwide [13]. In a
previous study we showed that low plasma level of total
adiponectin was an independent predictor for develop-
ment of glucose intolerance in this population [14]. Inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adiponectin and its multimers with diabetes mellitus.Subjects and methods
Subjects
The study population was selected from the Japanese
Brazilian Diabetes Study Group. Details on the selection
and recruitment of this population were previously de-
scribed [13]. For this study, we randomly selected a
small subset of non-related subjects with suitable baseline
serum specimens and normal glucose tolerance or dia-
betes mellitus matched for age and sex. Individuals with
impaired fasting glucose, impaired glucose tolerance or
severe kidney disease (eGFR < 30 mL/min/1.73 m2) were
excluded. A subset of 53 individuals was selected: 26
patients with diabetes mellitus (DM,14 women and 12
men, aged 55.3 ± 8.6 years) and 27 control subjects with
normal glucose tolerance (NGT,12 women and 15 men,
aged 54.0 ± 9.2 years). Individuals went through an inter-
view with questionnaires regarding social aspects and
medical history. Clinical examination was performed and
included anthropometric (weight, height, waist circumfer-
ence and hip circumference) and blood pressure measure-
ments. Fasting blood samples for glucose, insulin, lipids
and adiponectin were obtained. Morning medications
were deferred until all procedures were done. A 75 g an-
hydrous glucose was administered to all subjects with
fasting capillary glucose < 200 mg/dL screened by glucose-
oxidase strips. After 2 h another blood sample was obtained
for glucose measurements.
This study was approved by the Ethics Committee of
the Federal University of São Paulo, and all participants
gave their informed consent.Laboratory methods
Plasma glucose was determined by the glucose-oxidase
method. Cholesterol contents of lipoproteins fractions
and triglycerides were measured enzymatically. Insulin
was determined by a monoclonal antibody-based immu-
nofluorimetric assay (PerkinElmer, Wallac Oy, Turku,
Finland) that does not react with proinsulin. Insulin re-
sistance was estimated by homeostasis model assessment
(HOMA-IR) [15]. Estimated glomerular filtration rate
(eGFR) was determined by the Modification of Diet in
Renal Disease (MDRD) equation. Glucose tolerance status
was based on WHO criteria [16]. Serum total adiponectin
concentrations were measured by radio-immunoassay ac-
cording to manufacter’s instructions (Linco Research, St.
Charles, MI, USA) in specimens that had been stored
at −20°C. This assay utilizes 125I-labeled murine adiponectin
and a multi-species adiponectin antiserum. Samples were
diluted 1:500 in assay buffer prior to measurements. The
assay has a sensitivity of 1 ng/mL with an intra- and inter-assay coefficients of variation of 1,8-6,2% and 6,9-9,3%,
respectively.SDS-PAGE and immunoblotting for determination of
adiponetin multimers
The relative amounts of adiponectin multimers were de-
termined by Western blot analysis. Serum was diluted
10-fold with deionized water and 5 uL of this diluted
serum plus 5 uL of protein loading buffer was separated
under non-reducing and non-heat-denaturating condi-
tions on 4-12% polyacrylamide gel electrophoresis. SDS-
PAGE was performed according to standard Laemmli
procedure. Following electrophoresis, the proteins were
transferred to nitrocellulose membrane (Hybond ECL,
Amersham Biosciences, Piscataway, NJ, USA) and incu-
bated with blocking solution (5% nonfat milk in Tris-
buffered saline with 0.05% Tween 20) for 1 h at room
temperature. The blocking solution was removed and re-
placed with the same solution containing 1:10,000 dilution
of a mouse antihuman adiponectin monoclonal antibody
(BD Bioscience, San Jose, CA, USA). The incubation
was continued overnight at 4°C. After being washed the
nitrocellulose was incubated with horseradish peroxidase-
conjugated goat anti-mouse immunoglobulins (Santa Cruz
Biotechnology, Inc, Santa Cruz, CA, USA) with 1:5,000
dilution for 1 h at room temperature and washed thor-
oughly. Bands were detected by an enzymatic chemilumi-
nescent Western blot detection system (SuperSignal West
Pico Chemiluminescent Substrate, Thermo Fisher Scien-
tific, Rockford, IL, USA) and quantified by densitometry
analysis using the Image J software. Relative proportions
of adiponectin multimers were calculated by dividing
band density by total density in each lane. The absolute
adiponetin multimer values were extrapolated by multiply-
ing the relative proportions by the total adiponectin con-
centrations detected by RIA, assuming that all multimers
are immunoreactive on the immunoblot.Statistical analysis
Data with normal distribution, tested by Kolmogorov-
Smirnov test, are expressed as mean ± SD while variables
nonnormally distributed are reported as median (inter-
quartile range). Differences in continuous variables
between groups were evaluated by unpaired Student’s
test or Mann–Whitney test. The relative proportions of
adiponectin multimers between groups were compared
by using the Holling T2 test. Univariate associations
between variables were investigated by Spearman corre-
lation analysis. Logistic regression model was used to
identify independent associations with diabetes mellitus.
Model fit was assessed using the Akaike Information
Criterion. A P-value of < 0.05 was considered statistically
significant.
HMW
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The main characteristics of the study population are shown
in Table 1. Individuals with DM had significantly higher
BMI, waist circumference, triglycerides and HOMA-IR
than subjects with NGT. Figure 1 shows a representative
immunoblot from serum of age and sex matched individ-
uals with DM and NGT. Bands were found at > 300 kDa
representing HMW adiponectin, at ~180 kDa repre-
senting MMW adiponectin and at ~70 kDa representing
LMW adiponectin. As displayed in Figure 2, no significant
differences in total [NGT: 6.90 ug/ml (4.38-13.43); DM:Table 1 Characteristics of the subjects with normal
glucose tolerance (NGT) or diabetes mellitus (DM)
NGT (n = 27) DM (n = 26) P value
Age (years) 54.0 ± 9.2 55.3 ± 8.6 0.58a
BMI(kg/m2) 23.4 ± 2.4 25.1 ± 2.4 0.015a
Waist circumference
(cm)
79.4 ± 6.5 85.1 ± 7.6 0.005a
Waist-hip ratio 0.83 ± 0.05 0.88 ± 0.07 0.005a
Total cholesterol
(mg/dL)
200.9 ± 39.3 209.7 ± 33.4 0.384a
HDL-Cholesterol
(mg/dL)
48.8 ± 14.1 48.1 ± 8.4 0.809a
LDL-cholesterol
(mg/dL)
121.7 ± 39.1 126.4 ± 33.3 0.638a
Triglycerides
(mg/dL)
132.0 (97.2-171.5) 227.5 (160.0-380.0) 0.001b
Fasting plasma
glucose (mg/dL)
104.0 (100.2-107.7) 134.5 (127.0-170.0) <0.001b
Fasting plasma
insulin (uU/mL)
5.8 ± 2.7 9.4 ± 3.3 <0.001a
HOMA-IR 1.39 (0.96-1.75) 3.01 (2.63-3.83) <0.001b
eGFR (mL/min/1.73 m2) 98.1 ± 37.3 97.8 ± 32.8 0.97a
HbA1C (%) - 6.2 (5.7-7.1) -
Treatment for diabetes (n)
SU - 2 -
MTF - 1 -
SU + MTF - 1 -
SU + INS - 1 -
Treatment for hypertension (n)
B- blocker 1 - -
Diuretic 1 1 -
ACEi 1 1 -
B-blocker + diuretic 1 1 -
Treatment for dyslipidemia (n)
fibrate - 1 -
Data are presented as mean ± SD, median (interquartile range) or n.
SU: sulfonylrea; MTF: metformin; INS: insulin; ACEi: angiotensin-converting
enzyme inhibitor;
a t-test.
b Mann–Whitney test.
Figure 1 Representative immunoblot from serum of age and sex
matched subjects with NGT (lanes 1 and 2) and DM (lanes 3 and 4).
Band at > 300 kDa represents high molecular weight (HMW) adiponectin,
at ~180 kDa represents middle molecular weight (MMW) adiponectin
and at ~70 kDa represents low molecular weight (LMW) adiponectin.5.38 ug/ml (3.76-8.56), p = 0.35], MMW [NGT:2.34 ug/ml
(1.38-3.25); DM: 1.80 ug/ml (1.18-2.84), p = 0.48] or LMW
adiponectin [NGT: 2.07 ug/ml (1.45-3.48), DM: 2.93ug/ml
(1.78-3.99), p = 0.32] were found between groups. In con-
trast, HMW adiponectin levels were significantly lower
in patients with DM [NGT: 2.39 ug/ml (1.20-4.75);
DM: 1.04 ug/ml (0.42-1.60), p = 0.001]. The distribution
of adiponectin isoforms in subjects with NGT and DM
are shown in Figure 3. Lower proportions of HMW
adiponectin and higher proportions of LMW adiponectin
were observed in subjects with DM compared to NGT.
No differences were found in proportions of MMW
adiponectin.
Spearman rank correlation showed significant inverse
correlations between BMI (rs = − 0.29, p = 0.034), HOMA-
IR (rs = −0.36, p = 0.007) and triglycerides (rs = −0.22,
p = 0.04) with HMW adiponectin, MMW and LMW
adiponectin were significantly associated with waist circum-
ference (rs = −0.29, p = 0.03; rs = −0.28, p = 0.03 respec-
tively). A trend for inverse correlation between BMI and
total adiponectin (rs = − 0.27, p = 0.051) was observed. No
significant correlations were found for total adiponectin
with HOMA-IR or triglycerides.
A logistic regression analysis was done to identify inde-
pendent associations with diabetes mellitus. The covari-
ates were waist/hip ratio, triglycerides levels, HOMA-IR,
total and HMW adiponectin, including interaction with
sex for total and HMW adiponectin. The results showed
that HOMA-IR and HMW adiponectin in women were
independently associated with diabetes mellitus (Table 2).
Discussion
In the present study, we measured total plasma adiponectin
and its all three oligomeric isoforms in Japanese-Brazilians
to investigate their relationship with diabetes mellitus.
There are limited data concerning the role of these
Table 2 Odds ratio (OR) and 95% confidence interval (CI)
for diabetes mellitus according to biological variables
OR 95% CI
HMW adiponectin in women (for each 1%) 0.75 0.58-0.95
HMW adiponectin in men (for each 1%) 1.08 0.95-1.23
HOMA-IR (for each 0.1 unit) 1.53 1.12-2.09
Figure 2 Serum concentrations of total, low molecular weight
(LMW), middle molecular weight (MMW) and high molecular
weight (HMW) adiponectin in individuals with normal glucose
tolerance (NGT) or diabetes mellitus (DM). The box displays the
median and interquartile range (25th-75th percentile) and the whiskers
display the 10th and 90th values.
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adiponectin and HMW isoform.
Different methods have been employed for determin-
ation of adiponectin multimers such as velocity sedi-
mentation coupled to quantitative Western-blot analysis,
gel filtration chromatography and gel electrophoresis
[5,7,17,18]. Pajvani et al. developed a method of velocity
sedimentation analysis coupled to Western blot to sepa-
rate and measure the adiponectin complexes [17]. This
is a laborious technique and does not discriminate the
lower molecular weight complexes. More recently, Schraw
et al. validated a high-resolution gel filtration approach
followed by fluorescent Western blotting that separated
the three major adiponectin complexes in a reproducibly
and accurate manner [19]. Waki et al. using a SDS-PAGE
under non-reducing and non-heat-denaturing conditions
clearly separated the adiponectin multimers in to three
species and reported that this analysis was superior to the
gel filtration in terms of resolving power [7]. In this study,
it was employed SDS-PAGE under non-reducing and
non-heat-denaturing conditions to detect the isoforms. InFigure 3 Percentual distribution of low molecular weight (LMW), mid
adiponectin in individuals with normal glucose tolerance (NGT) or diaour hands, this procedure permitted a clear separation of
the three bands.
In previous studies we showed that in Japanese-
Brazilians, low plasma level of total adiponectin is an in-
dependent predictor of glucose intolerance and subjects
with type 2 diabetes compared with normal glucose tol-
erant subjects have reduced levels of total adiponectin
[14,20]. Here, in a small subset of this population, it was
found that HMW adiponectin is selectively reduced in
individuals with type 2 diabetes. As a consequence of a
drop in HMW, an increase in the percentage of LMW
was observed in individuals with DM compared to NGT.
A correlation between insulin sensitivity, evaluated by
HOMA-IR, and HMW adiponectin was observed. These
findings support the role of HMW adiponectin as the
major isoform mediating its insulin-sensitizing effects. Fur-
thermore, in women, an increase of HWW adiponectin
in percent has a significant decreased risk of diabetes
mellitus. This is in agreement with previous studies show-
ing that decreased HMW adiponectin is a better marker
than total adiponectin for assessing the risk of type 2 dia-
betes [8,21,22]. However, other data do not support the
superiority of HMW adiponectin in assessing parameters
of insulin resistance [23] or risk of type 2 diabetes [24].
MMW and LMW adiponectin isoforms have not been
extensively studied, as a result little is known regarding
their distribution. In the present study no differences
were found in MMW or LMW adiponectin between
groups. Schober et al., using ELISA to measure the three
isoforms, found that MMW and LMW adiponectin were
reduced in the serum of type 2 diabetic patients when com-
pared to normal weight controls [25]. However, Basu et al.
using velocity sedimentation/gel filtration chromatographydle molecular weight (MMW) and high molecular weight (HMW)
betes mellitus (DM).
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form from the remaining adiponectin isoforms found that
the concentration of LMW fractions (hexameric and tri-
meric forms) did not differ in the diabetic and nondiabetic
subjects [8,26]. These discrepancies may be explained by
different methods for determination of adiponectin mul-
timers or by ethnic differences.
Conclusions
The current investigation demonstrates that in Japanese-
Brazilians HMW adiponectin is selectively reduced in in-
dividuals with type 2 diabetes, while no differences were
found in MMW and LMW adiponectin isoforms.
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